Health Resource Utilization (HRU) and Costs for Metastatic Renal Cell Carcinoma (MRCC) Patients Treated With First-Line (1l) Systemic Therapy in The United States

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2332
https://www.valueinhealthjournal.com/article/S1098-3015(16)33698-1/fulltext
Title : Health Resource Utilization (HRU) and Costs for Metastatic Renal Cell Carcinoma (MRCC) Patients Treated With First-Line (1l) Systemic Therapy in The United States
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33698-1&doi=10.1016/j.jval.2016.09.2332
First page : A755
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 2214
Categories :
Tags :
Regions :
ViH Article Tags :